Severe pulmonary toxicity in a patient treated with gemcitabine

Manuel F. Rosado; Daniel H. Kett; Roland M.H. Schein; Francisco J. Baraona; Kasi S. Sridhar

doi:10.1097/00000421-200202000-00005

Severe pulmonary toxicity in a patient treated with gemcitabine

Manuel F. Rosado, Daniel H. Kett, Roland M.H. Schein, Francisco J. Baraona, Kasi S. Sridhar

Medicine

Research output: Contribution to journal › Article › peer-review

26 Scopus citations

Abstract

Gemcitabine is a pyrimidine analog of deoxycytidine with activity against nonhematologic and hematologic malignancies. Its pulmonary toxicity is usually mild and self-limiting. We describe a male patient with lung cancer in whom severe dyspnea and interstitial infiltrates developed after the administration of gemcitabine.

Original language	English (US)
Pages (from-to)	31-33
Number of pages	3
Journal	American Journal of Clinical Oncology: Cancer Clinical Trials
Volume	25
Issue number	1
DOIs	https://doi.org/10.1097/00000421-200202000-00005
State	Published - 2002

Keywords

Gemcitabine
Pulmonary toxicity

ASJC Scopus subject areas

Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1097/00000421-200202000-00005

Cite this

@article{53fc2c823e8f4c48807f3a59d0aaaece,

title = "Severe pulmonary toxicity in a patient treated with gemcitabine",

abstract = "Gemcitabine is a pyrimidine analog of deoxycytidine with activity against nonhematologic and hematologic malignancies. Its pulmonary toxicity is usually mild and self-limiting. We describe a male patient with lung cancer in whom severe dyspnea and interstitial infiltrates developed after the administration of gemcitabine.",

keywords = "Gemcitabine, Pulmonary toxicity",

author = "Rosado, {Manuel F.} and Kett, {Daniel H.} and Schein, {Roland M.H.} and Baraona, {Francisco J.} and Sridhar, {Kasi S.}",

year = "2002",

doi = "10.1097/00000421-200202000-00005",

language = "English (US)",

volume = "25",

pages = "31--33",

journal = "American Journal of Clinical Oncology",

issn = "0277-3732",

publisher = "Lippincott Williams and Wilkins",

number = "1",

}

TY - JOUR

T1 - Severe pulmonary toxicity in a patient treated with gemcitabine

AU - Rosado, Manuel F.

AU - Kett, Daniel H.

AU - Schein, Roland M.H.

AU - Baraona, Francisco J.

AU - Sridhar, Kasi S.

PY - 2002

Y1 - 2002

N2 - Gemcitabine is a pyrimidine analog of deoxycytidine with activity against nonhematologic and hematologic malignancies. Its pulmonary toxicity is usually mild and self-limiting. We describe a male patient with lung cancer in whom severe dyspnea and interstitial infiltrates developed after the administration of gemcitabine.

AB - Gemcitabine is a pyrimidine analog of deoxycytidine with activity against nonhematologic and hematologic malignancies. Its pulmonary toxicity is usually mild and self-limiting. We describe a male patient with lung cancer in whom severe dyspnea and interstitial infiltrates developed after the administration of gemcitabine.

KW - Gemcitabine

KW - Pulmonary toxicity

UR - http://www.scopus.com/inward/record.url?scp=0036159592&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036159592&partnerID=8YFLogxK

U2 - 10.1097/00000421-200202000-00005

DO - 10.1097/00000421-200202000-00005

M3 - Article

C2 - 11823691

AN - SCOPUS:0036159592

VL - 25

SP - 31

EP - 33

JO - American Journal of Clinical Oncology

JF - American Journal of Clinical Oncology

SN - 0277-3732

IS - 1

ER -

Severe pulmonary toxicity in a patient treated with gemcitabine

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this